Wastewater Data Show Texas and Mississippi Driving a Late Summer COVID-19 Uptick
On Aug. 23, 2026, The Centers for Disease Control and Prevention’s (CDC) national wastewater surveillance system, which tracks…
-
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics
HHS Secretary Signs COVID-19 Emergency Use Authorization Declaration Terminations
On Jun. 30, 2026, The U.S. Department of Health and Human Services (HHS) announced that Secretary Robert F….
-
UK Trials Show Paxlovid speeds recovery, but doesn’t reduce hospitalization in vaccinated patients
On Apr. 23, 2026. two national trials published in the New England Journal of Medicine report Paxlovid (nirmatrelvir-ritonavir)…
-
Biotechnology | CDC | COVID-19 | Diagnostics | Infectious Disease | NIH | Vaccine
CDC Reported 10,000–23,000 RSV deaths in 2025
On Feb. 19, 2026, the U.S. Centers for Disease Control and Prevention (CDC) reported severe outcomes from COVID-19…
-
Study Shows SARS-CoV-2 RNA found in 39% of hospital air samples during outbreaks, despite good ventilation
On Feb. 17, 2026, a new study published in Respiratory Medicine show COVID-19 genetic material was frequently detected in…
-
WHO Releases Statement on the antigen composition of COVID-19 vaccines
On Dec. 18, 2025, the World Health Organization (WHO) Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) announced…
-
Biotechnology | COVID-19 | Diagnostics | Environmental | Forestry | Infectious Disease | Influenza | Measles | Plague | Polio | U.S. Congress | Vaccine
Decoding Wildlife Movement to Predict the Next Pandemic
Sept. 15, 2025, a groundbreaking new study led by Prof. Ran Nathan from the Movement Ecology Lab at the Hebrew University…
-
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
On Sept. 8, 2025, Pfizer and BioNTech announced positive topline results from an ongoing Phase 3 clinical trial…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
On Jul. 22, 2025, AstraZeneca announces $50 billion of investment in the United States by 2030, building on…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
WHO Scientific advisory group issues report on origins of COVID-19
On Jun. 27, 2025, the World Health Organization (WHO) Scientific Advisory Group for the Origins of Novel Pathogens…
-
Cardiology | COVID-19 | Disease | Environmental | Infectious Disease | Influenza | Measles | Oncology | Vaccine
U.S. excess deaths continued to rise even after the COVID-19 pandemic
On May 23, 2025, a Boston University School of Public Health (BUSPH) led study revealed that there were…
-
U.S. Hospitals No longer Required to Report COVID-19 Infection Data
On May 1, 2025, the U.S. Centers for Disease Control and Prevention (CDC) announced that hospitals are no…
-
Agriculture | Artificial Intelligence | Biotechnology | COVID-19 | Diagnostics | Energy | Environmental | EPA | FDA | Forestry | Genomics | HIV | Infectious Disease | Influenza | Measles | Medicine | Nanotechnology | Neurology | NIH | Non-Profit Research | Oncology | Pharmaceutical | Polio | Stem Cell | Therapeutics | USDA | Vaccine | Veterinary | Women's Health
Cartoon Illustrating “The NIH and U.S. Healthcare in Crisis” Published
On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…
-
Moderna’s UK Manufacturing Facility Received Manufacturing License from the MHRA
On Apr. 15, 2025, Moderna announced that its manufacturing facility in Harwell, Oxfordshire, the Moderna Innovation and Technology…
-
SHIELD-Utah Study Shows Novavax’s COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA
On Apr. 15, 2025, Novavax announced preliminary results from the SHIELD-Utah study (Study of Healthcare Workers and First…
-
Biotechnology | COVID-19 | Infectious Disease | Influenza | Measles | Plague | Polio | Therapeutics | Vaccine | WHO
WHO brings countries together to test collective pandemic response
On Apr. 4, 2025, the World Health Organization (WHO) announced that over the past two days, it convened…
-
Biotechnology | COVID-19 | Diagnostics | HIV
Novel point-of-care technology delivers accurate HIV results in minutes
On Apr. 2, 2025, A team of Northwestern University scientists spanning disciplines announced they have developed new technology…
-
Agriculture | Biotechnology | COVID-19 | Diagnostics | FDA | Genomics | Infectious Disease | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress
Defending Science and Reason
Defending Science and Reason requires continually suffering the slings and arrows from the army of doubters who embrace…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine | WHO
SARS-CoV-2 virus circulates Worldwide without clear seasonality and continues to infect
On Dec. 24, 2024, the World Health Organization (WHO) announced that SARS-CoV-2, the virus that causes COVID-19, largely…
-
Africa CDC Deployed Experts to Investigate unknown Disease X outbreak in Democratic Republic of Congo
On Dec. 9, 2024, the Africa Centers for Disease Control (CDC) announced that it is working closely with…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | NIH | Vaccine
Wuhan lab samples hold no clues relatives to virus behind COVID
On Dec. 6, 2024, Shi Zhengli, the Chinese virologist at centre of COVID lab-leak theory, has presented evidence…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Neurology | NIH | Non-Profit Research | Therapeutics | Vaccine
Study Found Persistent Infection Could Explain Long COVID in Some People
On Oct. 9, 2024, researchers from Brigham and Women’s Hospital found that people with wide-ranging long COVID symptoms…
-
epicenter of COVID-19 pandemic Genetically traced to market wildlife and viruses
On Sept. 19, 2024, an international team of researchers announced a study that genetically traced the epicenter of…
-
Study Revealed How COVID-19 Infection Can Cause or Worsen Diabetes
On Sept. 13, 2024, researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the…
-
Japan’s MHLW Approved CSL and Arcturus Therapeutics’ Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma
On Sept. 13, 2024, CSL Seqirus and sa-mRNA pioneer Arcturus Therapeutics announced that Japan’s Ministry of Health, Labor…
-
Covid-19 pandemic changed scientific publishing
On Sep. 9, 2024, Santo Fortunato, a professor at Luddy School of Informatics, reported that an international research…
-
Novavax Formula COVID-19 Vaccine Authorized and Recommended for Use in the U.S.
On Aug. 30, 2024, Novavax announced the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705) had received Emergency Use…
-
Vaccine Misinformation caused U.S. Covid-19 Vaccination rate to Drop
On Aug. 28, 2024, with the nation in the midst of a summer surge of Covid-19 infections and…
-
Pfizer and BioNTech Received U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vaccine
On Aug. 22, 2024, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had approved…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Vaccine | WHO
WHO/Europe study confirmed lifesaving impact of vaccines against COVID-19 Summer Wave
On Aug. 2, 2024, the World Health Organization (WHO) announced results of a study that showed the introduction…
